Crown Bioscience a global contract research organization CRO and JSR Life Sciences company has announced that its collaborative work with HanX Biopharmaceutical Co. Ltd. HanX employing a unique and broad portfolio of preclinical modeling in support of HanXs successful FDA Investigational New Drug IND application has been published in Scientific Reports a journal within the Nature portfolio.
Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, announced today that it has completed its acquisition of the IndivuServ business unit of Indivumed GmbH
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH.
Acquisition expands global service offering to include access and analysis of unique clinical biospecimens Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences